Suppr超能文献

新兴的抗人类腺病毒感染治疗药物:最新进展和新策略。

Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.

机构信息

Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada.

Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USA.

出版信息

Antiviral Res. 2021 Apr;188:105034. doi: 10.1016/j.antiviral.2021.105034. Epub 2021 Feb 10.

Abstract

Human adenoviruses (HAdV) are ubiquitous human pathogens that cause a significant burden of respiratory, ocular, and gastrointestinal illnesses. Although HAdV infections are generally self-limiting, pediatric and immunocompromised individuals are at particular risk for developing severe disease. Currently, no approved antiviral therapies specific to HAdV exist. Recent outbreaks underscore the need for effective antiviral agents to treat life-threatening infections. In this review we will focus on recent developments in search of potential therapeutic agents for controlling HAdV infections, with a focus on those targeting post-entry stages of the virus replicative cycle.

摘要

人类腺病毒(HAdV)是普遍存在的人类病原体,可引起呼吸道、眼部和胃肠道疾病,造成巨大负担。尽管 HAdV 感染通常是自限性的,但儿科和免疫功能低下者特别容易发生严重疾病。目前,尚无针对 HAdV 的批准抗病毒疗法。最近的疫情突显了需要有效的抗病毒药物来治疗危及生命的感染。在这篇综述中,我们将重点关注寻找控制 HAdV 感染的潜在治疗药物的最新进展,重点关注针对病毒复制周期进入后阶段的药物。

相似文献

9
Antiadenovirus drug discovery: potential targets and evaluation methodologies.抗腺病毒药物研发:潜在靶点与评估方法
Drug Discov Today. 2015 Oct;20(10):1235-42. doi: 10.1016/j.drudis.2015.07.007. Epub 2015 Jul 23.

引用本文的文献

8
Adenovirus infections: new insights for the clinical laboratory.腺病毒感染:临床实验室的新见解。
J Clin Microbiol. 2024 Sep 11;62(9):e0083622. doi: 10.1128/jcm.00836-22. Epub 2024 Aug 27.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验